Oncology Research Capabilities
1000+ drugs and drug combinations evaluated
Amenable to all injectable drug formulations
Spatial profiling of the TME response
Multiplex IHC + image analysis
Preclinical studies in tumor models
Scientific support + project management
BIOLOGY-DRIVEN INSIGHTS THROUGH OUR UNIQUELY INTEGRATED CLINICAL AND PRECLINICAL RESEARCH CAPBILITIES
Our approach enables increased understanding of complex drug/tumor interactions to guide development of your early pipeline assets. We track drug exposure and provide superior analysis of the TME response.
Compare drug and combination effects directly in the intact tumor microenvironment
Spatial Biology Analysis
Localized Response Data
Preclinical CIVO Offerings Available
CIVO highlights immune effects in syngeneic models
Preclinical CIVO Offerings Available
CIVO highlights immune effects in syngeneic models
- Experienced preclinical team
- In-house vivarium & IACUC
- Full tumor model, histology and image analysis support
- Excellent for pilot studies prior to Clinical CIVO
- Amenable to ALL drug modalities
- Small molecule
- I-O biologics
- Complex biologics (antibody-drug conjugates
- Novel delivery nanoparticles (exp. Exosomes)
- Live cell therapies (exp. CAR-T)
- Any combination of the above without drug reformulation!
Presage's Partners
A pioneering solution, turnkey operation, revenue-generating partnerships2016 - 2021
Previous image
Next image
